Table
1: Clinical
characteristics
|
Variable |
Group 1 (n = 132) Hyperuricemia |
Group 2 (n = 28) Free of hyperuricemia |
P |
|
Age at Transplant |
3.1 ± 9.7 |
35.5 ± 11.9 |
0.07 |
|
Female n, % |
55 (40) |
11 (39) |
0.87 |
|
Hypertension n, % |
98 (72) |
21 (75) |
0.75 |
|
Diabetes Mellitus n, % |
15 (11) |
4 (14) |
0.51 |
|
Dyslipidemia n, % |
80 (58) |
10 (35) |
0.02 |
|
Body Mass Index |
23.1 ± 4.1 |
22.4 ± 2.8 |
0.29 |
|
Cyclosplorine A n, % |
118 (86) |
21 (75) |
0.13 |
|
Mycophenolate mofetil n, % |
58 (42) |
2 (7) |
0.001 |
|
Azathioprine n, % |
126 (92) |
24 (85) |
0.43 |
|
Tacrolimus n, % |
20 (14) |
7 (25) |
0.24 |